Completed
Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
NCT03610516
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- Novartis Investigative Site Córdoba, Argentina
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Changsha, Hunan, China